View Single Post
Old 08-19-2007, 11:26 PM
Posts: n/a
Default No Subject

I am currently receiving intravenous doses of zometa every six months in a drug study with the cancer drug femara. Femara is an aromatase inhibitor used in the treatment of breast cancer. The study is to see if the Zometa will stop the bone lose caused by this family of drugs.
Reply With Quote